Developer docs
API playgroundTry for free, no card

Search company profiles

Hayden Consulting Group

Full company profile

uuid000ah3e

Namestring
Hayden Consulting Group
Legal namestring
Hayden Consulting Group, LLC
Websiteurl
haydencg.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Hayden Consulting Group, LLC is a Boston-headquartered strategy and analytics consulting firm founded in October 2019 by Jamie Sidore and David MacDougall, with a secondary office opened in Brooklyn in March 2024. The firm serves biopharmaceutical and life sciences clients, providing market access, payer and reimbursement, patient services, commercial due diligence, and new product planning advisory work, alongside data and analytics services built on SQL-based analysis and primary market research (PMR) methodologies. Hayden's core IP is the "Access Forward" framework, which positions access as the #1 driver of commercial success and integrates access considerations across brand strategy, launch execution, and lifecycle management.

The firm's revenue model is professional services consulting delivered through direct enterprise engagement with pharmaceutical and life sciences leadership on a project and retainer basis; pricing is not publicly disclosed and is scoped per engagement. Hayden invests heavily in thought leadership, publishing recurring content (2026 Access Pulse Check, PBM compensation series, IRA Maximum Fair Price analysis, Oncology Tug-of-War) to maintain category authority in U.S. market access. The firm claims a 44.7% average profit increase per client investment, though this is a vendor-reported metric.

On January 7, 2026, Hayden was acquired by BGB Group, a New York-based medical marketing agency with $145 million in 2024 revenue. The firm was integrated into BGB's Strategic Advisory practice under Chief of Commercial Strategy and Innovation Hilary Gentile, with co-founders Sidore and MacDougall retaining leadership and approximately 80-100 Hayden employees moving across. Hayden now operates as part of BGBx Consulting, with the Hayden brand retained for continuity of client relationships.

Short descriptiontext

Hayden Consulting Group is a Boston-based life sciences consultancy advising biopharmaceutical clients on market access, payer strategy, patient services, and commercial planning through data analytics and primary market research. Now part of BGBx Consulting following its January 2026 acquisition by BGB Group.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
market access consulting, life sciences strategy, pharmaceutical consulting, patient services advisory, payer reimbursement strategy
Industry3 codes
PRIMARYBPAHACAA
Strategy & Corporate Development Consulting
SECONDARYBPAHACAG
Customer, Marketing & Sales Consulting
SECONDARYBPAHACAB
Operations & Process Improvement Consulting
NAICS code3 codes
  • Management Consulting Services54161
  • Other Management Consulting Services541618
  • Marketing Consulting Services541613
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Market Access Consulting
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Consulting Services
TypeProfessional Services
Description

Professional consulting services delivered to biopharmaceutical clients on a project and retainer basis. Revenue derived from strategic advisory engagements focused on market access, commercial strategy, and patient services.

mmm-online.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Hayden Consulting Group is a strategy and analytics consulting firm that helps life sciences companies untangle access complexity, uncover deep insights through data analytics and primary market research, and unlock commercial success. The firm delivers market access, payer/reimbursement, patient services, and commercial strategy advisory services to pharmaceutical and biopharmaceutical clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 44.7% average profit increase per client investment with Hayden
Product overview1 text field

Hayden Consulting Group is a premier market access and patient services consultancy that operates as a single unified consulting practice offering specialized services to life sciences companies. The firm provides integrated market access consulting, combining data analytics, primary market research, and strategic advisory services to help pharmaceutical brands navigate payer, pricing, and reimbursement challenges. Hayden's core offerings center on untangling access complexity, uncovering deep insights through analytics and research, and unlocking commercial success for clients. The company was acquired by BGB Group in January 2026 and now operates as part of BGBx Consulting's Strategic Advisory practice.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-07
Description

BGB Group, a New York-based medical marketing agency, acquired Hayden Consulting Group on January 7, 2026. Hayden was integrated into BGB's Strategic Advisory practice under Chief of Commercial Strategy and Innovation Hilary Gentile. The combination aims to provide biopharmaceutical clients with comprehensive solutions spanning commercial due diligence, new product planning, market access, and patient services.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Trinity Life Sciences offers strategic advisory, primary market research, and analytics to pharma clients, with strong overlap to Hayden's commercial strategy, market access, and patient services work.

2ZS Associates
TypeDirect peer
Description

ZS Associates is one of the largest dedicated life sciences consulting firms with a market access and pricing practice serving global pharma clients. Like Hayden, ZS combines analytics, primary research, and strategic advisory for payer and commercialization challenges, making it the closest direct comparable in scale and offering.

TypeBroad incumbent
Description

IQVIA is the dominant global life sciences data, analytics, and consulting platform with a substantial market access and payer evidence practice. It competes with Hayden on pharma commercial strategy engagements while offering much broader data assets and global scale.

TypeDirect peer
Description

Health Advances is a boutique life sciences strategy consulting firm focused on commercial strategy, market access, and new product planning for pharma and medtech. Its therapeutic-area depth and project-based delivery model closely mirrors Hayden's approach.

TypeBroad incumbent
Description

CRA's Life Sciences Practice delivers strategy consulting on commercial, market access, and pricing for pharma and biotech. It is a broader, publicly-traded competitor with overlapping market access capabilities.

TypeBroad incumbent
Description

Eversana is a large commercial services platform for life sciences with dedicated market access and patient services practices. It competes with Hayden on patient services consulting and access strategy while offering broader commercialization services.

TypeDirect peer
Description

Avalere Health combines policy, evidence, and market access advisory including the former Putnam Associates practice. Its payer strategy and access work for pharma directly competes with Hayden's payer and reimbursement engagements.

TypeDirect peer
Description

PRECISION Value & Evidence specializes in market access, health economics, and payer strategy for life sciences companies. Its focused service portfolio on payer access, value communication, and reimbursement strategy directly overlaps with Hayden's commercial strategy and patient services work.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hayden Consulting Group

Pharmaceutical Market Access Consultinghaydencg.com

Hayden Consulting Group is a Boston-based life sciences consultancy advising biopharmaceutical clients on market access, payer strategy, patient services, and commercial planning through data analytics and primary market research. Now part of BGBx Consulting following its January 2026 acquisition by BGB Group.

What Hayden Consulting Group does

Hayden Consulting Group, LLC is a Boston-headquartered strategy and analytics consulting firm founded in October 2019 by Jamie Sidore and David MacDougall, with a secondary office opened in Brooklyn in March 2024. The firm serves biopharmaceutical and life sciences clients, providing market access, payer and reimbursement, patient services, commercial due diligence, and new product planning advisory work, alongside data and analytics services built on SQL-based analysis and primary market research (PMR) methodologies. Hayden's core IP is the "Access Forward" framework, which positions access as the #1 driver of commercial success and integrates access considerations across brand strategy, launch execution, and lifecycle management.

The firm's revenue model is professional services consulting delivered through direct enterprise engagement with pharmaceutical and life sciences leadership on a project and retainer basis; pricing is not publicly disclosed and is scoped per engagement. Hayden invests heavily in thought leadership, publishing recurring content (2026 Access Pulse Check, PBM compensation series, IRA Maximum Fair Price analysis, Oncology Tug-of-War) to maintain category authority in U.S. market access. The firm claims a 44.7% average profit increase per client investment, though this is a vendor-reported metric.

On January 7, 2026, Hayden was acquired by BGB Group, a New York-based medical marketing agency with $145 million in 2024 revenue. The firm was integrated into BGB's Strategic Advisory practice under Chief of Commercial Strategy and Innovation Hilary Gentile, with co-founders Sidore and MacDougall retaining leadership and approximately 80-100 Hayden employees moving across. Hayden now operates as part of BGBx Consulting, with the Hayden brand retained for continuity of client relationships.

Hayden Consulting Group firmographics

Firmographics
Name
Hayden Consulting Group
Legal name
Hayden Consulting Group, LLC
Website
https://haydencg.com
Company type
Private
Founded year
2019
Operating status
Acquired
Headcount range
51–100 employees
Short description
Hayden Consulting Group is a Boston-based life sciences consultancy advising biopharmaceutical clients on market access, payer strategy, patient services, and commercial planning through data analytics and primary market research. Now part of BGBx Consulting following its January 2026 acquisition by BGB Group.
Ownership category
akta.pro rank

Hayden Consulting Group industry classification

Industry
Product category
Pharmaceutical Market Access Consulting
NAICS
Management Consulting Services (54161), Other Management Consulting Services (541618), Marketing Consulting Services (541613)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYBPAHACAA
Strategy & Corporate Development Consulting
SECONDARYBPAHACAG
Customer, Marketing & Sales Consulting
SECONDARYBPAHACAB
Operations & Process Improvement Consulting

Keywords

  • Market access consulting
  • Life sciences strategy
  • Pharmaceutical consulting
  • Patient services advisory
  • Payer reimbursement strategy

Where Hayden Consulting Group is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Hayden Consulting Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Consulting Services: Professional consulting services delivered to biopharmaceutical clients on a project and retainer basis. Revenue derived from strategic advisory engagements focused on market access, commercial strategy, and patient services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Hayden Consulting Group product offering

Product offering

Core offering

Hayden Consulting Group is a strategy and analytics consulting firm that helps life sciences companies untangle access complexity, uncover deep insights through data analytics and primary market research, and unlock commercial success. The firm delivers market access, payer/reimbursement, patient services, and commercial strategy advisory services to pharmaceutical and biopharmaceutical clients.

Product overview

Hayden Consulting Group is a premier market access and patient services consultancy that operates as a single unified consulting practice offering specialized services to life sciences companies. The firm provides integrated market access consulting, combining data analytics, primary market research, and strategic advisory services to help pharmaceutical brands navigate payer, pricing, and reimbursement challenges. Hayden's core offerings center on untangling access complexity, uncovering deep insights through analytics and research, and unlocking commercial success for clients. The company was acquired by BGB Group in January 2026 and now operates as part of BGBx Consulting's Strategic Advisory practice.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 44.7% average profit increase per client investment with Hayden

Companies that use Hayden Consulting Group

Customer profile

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Hayden Consulting Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Hayden Consulting Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • BGB GroupcoreStrategic or Co-development Partner · 7 January 2026BGB Group, a New York-based medical marketing agency, acquired Hayden Consulting Group on January 7, 2026. Hayden was integrated into BGB's Strategic Advisory practice under Chief of Commercial Strategy and Innovation Hilary Gentile. The combination aims to provide biopharmaceutical clients with comprehensive solutions spanning commercial due diligence, new product planning, market access, and patient services.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Hayden Consulting Group competitors and assessment

Company assessment

Direct peers

  • Trinity Life Sciences: Trinity Life Sciences offers strategic advisory, primary market research, and analytics to pharma clients, with strong overlap to Hayden's commercial strategy, market access, and patient services work.
  • ZS Associates: ZS Associates is one of the largest dedicated life sciences consulting firms with a market access and pricing practice serving global pharma clients. Like Hayden, ZS combines analytics, primary research, and strategic advisory for payer and commercialization challenges, making it the closest direct comparable in scale and offering.
  • Health Advances: Health Advances is a boutique life sciences strategy consulting firm focused on commercial strategy, market access, and new product planning for pharma and medtech. Its therapeutic-area depth and project-based delivery model closely mirrors Hayden's approach.
  • Avalere Health (Putnam Associates): Avalere Health combines policy, evidence, and market access advisory including the former Putnam Associates practice. Its payer strategy and access work for pharma directly competes with Hayden's payer and reimbursement engagements.
  • Precision Value & Evidence (PRECISION): PRECISION Value & Evidence specializes in market access, health economics, and payer strategy for life sciences companies. Its focused service portfolio on payer access, value communication, and reimbursement strategy directly overlaps with Hayden's commercial strategy and patient services work.

Broad incumbents

  • IQVIA (Market Access & Consulting): IQVIA is the dominant global life sciences data, analytics, and consulting platform with a substantial market access and payer evidence practice. It competes with Hayden on pharma commercial strategy engagements while offering much broader data assets and global scale.
  • Charles River Associates (Life Sciences Practice): CRA's Life Sciences Practice delivers strategy consulting on commercial, market access, and pricing for pharma and biotech. It is a broader, publicly-traded competitor with overlapping market access capabilities.
  • Eversana: Eversana is a large commercial services platform for life sciences with dedicated market access and patient services practices. It competes with Hayden on patient services consulting and access strategy while offering broader commercialization services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Hayden Consulting Group social profiles

Digital presence

Hayden Consulting Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hayden Consulting Group leadership team

Management profile

Number of profiles

Profiles12 records

Hayden Consulting Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hayden Consulting Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hayden Consulting Group

What does Hayden Consulting Group do?

Hayden Consulting Group is a strategy and analytics consulting firm that helps life sciences companies untangle access complexity, uncover deep insights through data analytics and primary market research, and unlock commercial success. The firm delivers market access, payer/reimbursement, patient services, and commercial strategy advisory services to pharmaceutical and biopharmaceutical clients.

Is Hayden Consulting Group a public or private company?

Hayden Consulting Group is a private company. It is classified as corporate owned and is currently acquired.

When was Hayden Consulting Group founded?

Hayden Consulting Group was founded in 2019. It employs 51 to 100 people.

Where is Hayden Consulting Group based?

Hayden Consulting Group is headquartered in Boston, United States, in the North America region.

How does Hayden Consulting Group make money?

One revenue line is on record: consulting Services.

Who are Hayden Consulting Group's main competitors?

Direct peers on record are Trinity Life Sciences, ZS Associates, Health Advances, Avalere Health (Putnam Associates) and Precision Value & Evidence (PRECISION). Broad incumbents are IQVIA (Market Access & Consulting), Charles River Associates (Life Sciences Practice) and Eversana.

Does Hayden Consulting Group have an API?

No public API is recorded for Hayden Consulting Group.

What industry is Hayden Consulting Group in?

Hayden Consulting Group's product category is Pharmaceutical Market Access Consulting. Its primary akta.pro industry code is BPAHACAA, Strategy & Corporate Development Consulting, with a secondary code of BPAHACAG, Customer, Marketing & Sales Consulting. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ClearsightadvisorsClearsight Advises Hayden Consulting Group in its Acquisition by BGB GroupClearsight Advisors advised Hayden Consulting Group in its acquisition by BGB Group, a TPG portfolio company. The deal combines Hayden's market access expertise with BGB's commercial solutions, creating an expanded Strategic Advisory practice. Quotes from Hayden and Clearsight executives highlight the transaction's significance.GlobeNewswireBGB Group Acquires Hayden Consulting Group to Bolster Market Access and Patient ServicesBGB Group acquired Hayden Consulting Group, a market access and patient services consultancy, to integrate its expertise with BGB's strategic advisory services. The combined offering spans commercial due diligence, new product planning, go-to-market strategy, and market access, with Hayden continuing under its co-founders. Financial terms were not disclosed.BgbgroupBGB Group Acquires Hayden Consulting GroupBGB Group announced on January 7, 2026 the acquisition of Hayden Consulting Group, a premier market access and patient services consultancy. Hayden, co-founded by Jamie Sidore and David MacDougall, will be integrated into BGB's Strategic Advisory practice under Chief of Commercial Strategy and Innovation Hilary Gentile. The combination aims to provide biopharmaceutical clients with comprehensive solutions spanning commercial due diligence, new product planning, market access, and patient services, with financial terms undisclosed.GlobeNewswireBGB Group Acquires Hayden Consulting Group to Bolster Market Access and Patient ServicesBGB Group announced the acquisition of Hayden Consulting Group, a premier market access and patient services consultancy specializing in payer, reimbursement, and affordability challenges for global pharmaceutical brands. The deal combines Hayden's market access expertise with BGB's Strategic Advisory services to offer clients integrated solutions spanning commercial due diligence, new product planning, and go-to-market strategy. Financial terms were not disclosed; Hayden will continue to be led by its co-founders Jamie Sidore and David MacDougall and operate as part of BGB's Strategic Advisory practice.Mmm-onlineBGB Group scoops up market access shop Hayden Consulting GroupBGB Group, a New York-based medical marketing agency, acquired Boston-based Hayden Consulting Group, a market access consultancy, integrating approximately 80 to 100 Hayden employees into its Strategic Advisory practice. The deal fills a gap in BGB's payer consulting capabilities and strengthens its ability to help pharma and life sciences clients navigate payer, pricing, and reimbursement challenges in the U.S. and global markets. BGB reported $145 million in 2024 revenue, a 4% increase, with nearly half of that growth coming from new clients.YahooBGB Group Acquires Hayden Consulting Group to Bolster Market Access and Patient ServicesBGB Group announced the acquisition of Hayden Consulting Group, a premier market access and patient services consultancy. The deal combines Hayden's payer, reimbursement, and affordability expertise with BGB's existing Strategic Advisory services to offer comprehensive commercial solutions across the full pharmaceutical brand lifecycle. Hayden's co-founders Jamie Sidore and David MacDougall will continue to lead the firm as part of BGB's Strategic Advisory practice, led by Hilary Gentile.